Your browser doesn't support javascript.
loading
Effect of YC-1102 on the Improvement of Obesity in High-Fat Diet-Induced Obese Mice.
Yu, Hwa-Young; Kim, Kyoung Kon; Baek, Sin Hwa; Park, Cho I; Jeon, Hye Jin; Song, Ae Ri; Park, Hyun-Je; Park, Il Bum; Kang, Jong Soo; Kim, Jung Min; Kim, Tae Woo; Jang, Sun Min; Cha, Joo Young; Kim, Junghyun.
Affiliation
  • Yu HY; Department of Oral Pathology, School of Dentistry, Jeonbuk National University, Jeonju 54907, Republic of Korea.
  • Kim KK; Newgen Healthcare Co., Ltd., 56 Soyanggang-ro, Chuncheon-si 24232, Republic of Korea.
  • Baek SH; Yuhan Care Co., Ltd., Yuhan Care R&D Center, Yongin-si 17084, Republic of Korea.
  • Park CI; Yuhan Care Co., Ltd., Yuhan Natural Product R&D Center, Andong-si 36618, Republic of Korea.
  • Jeon HJ; Yuhan Care Co., Ltd., Yuhan Care R&D Center, Yongin-si 17084, Republic of Korea.
  • Song AR; Yuhan Care Co., Ltd., Yuhan Natural Product R&D Center, Andong-si 36618, Republic of Korea.
  • Park HJ; Yuhan Care Co., Ltd., Yuhan Care R&D Center, Yongin-si 17084, Republic of Korea.
  • Park IB; Yuhan Care Co., Ltd., Yuhan Natural Product R&D Center, Andong-si 36618, Republic of Korea.
  • Kang JS; Yuhan Care Co., Ltd., Yuhan Care R&D Center, Yongin-si 17084, Republic of Korea.
  • Kim JM; Yuhan Care Co., Ltd., Yuhan Natural Product R&D Center, Andong-si 36618, Republic of Korea.
  • Kim TW; Yuhan Care Co., Ltd., Yuhan Care R&D Center, Yongin-si 17084, Republic of Korea.
  • Jang SM; Yuhan Care Co., Ltd., Yuhan Natural Product R&D Center, Andong-si 36618, Republic of Korea.
  • Cha JY; Yuhan Care Co., Ltd., Yuhan Care R&D Center, Yongin-si 17084, Republic of Korea.
  • Kim J; Yuhan Care Co., Ltd., Seoul 07335, Republic of Korea.
Curr Issues Mol Biol ; 46(2): 1437-1450, 2024 Feb 07.
Article de En | MEDLINE | ID: mdl-38392211
ABSTRACT
Obesity is one of the major risk factors for metabolic diseases worldwide. This study examined the effects of YC-1102, an extract derived from the roots of Rosa multiflora, on 3T3-L1 preadipocytes and high-fat diet (HFD)-induced obese mice. In vivo experiments involved the oral administration of YC-1102 (100, 150, and 200 mg/kg body weight) daily to mice for eight weeks. YC-1102 was found to downregulate the expressions of PPARγ and C/EBPα during adipogenesis, inhibiting adipocyte differentiation and upregulating the expression of PGC-1α for energy metabolism to enhance mitochondrial biogenesis and fatty acid oxidation. It has been shown that daily administration of YC-1102 to mice receiving a HFD prevented an increase in body weight and the accumulation of body fat. YC-1102 administration also reduced TG, TC, and LDL cholesterol levels, as well as glucose and leptin levels, and increased adiponectin levels, thus effectively inhibiting the metabolism of lipids. YC-1102-treated mice showed significant reductions in the mRNA expression of PPARγ and C/EBPα. The levels of PGC-1α involved in energy metabolism increased significantly in the YC-1102-treated mice when compared to the HFD-treated mice. According to the findings of this study, YC-1102 has a dual mechanism that reduces transcription factors that promote the differentiation of adipocytes and increases transcription factors that promote energy consumption.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Curr Issues Mol Biol Sujet du journal: BIOLOGIA MOLECULAR Année: 2024 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Curr Issues Mol Biol Sujet du journal: BIOLOGIA MOLECULAR Année: 2024 Type de document: Article